Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

Does ECONAZOLE Cause Product use in unapproved indication? 17 Reports in FDA Database

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

According to the FDA Adverse Event Reporting System (FAERS), 17 reports of Product use in unapproved indication have been filed in association with ECONAZOLE (Econazole Nitrate). This represents 3.8% of all adverse event reports for ECONAZOLE.

17
Reports of Product use in unapproved indication with ECONAZOLE
3.8%
of all ECONAZOLE reports
0
Deaths
1
Hospitalizations

How Dangerous Is Product use in unapproved indication From ECONAZOLE?

Of the 17 reports, 1 (5.9%) required hospitalization.

Is Product use in unapproved indication Listed in the Official Label?

This adverse event is not currently listed in the official FDA drug label for ECONAZOLE. However, 17 reports have been filed with the FAERS database.

What Other Side Effects Does ECONAZOLE Cause?

Drug ineffective (62) Rash maculo-papular (44) Acute generalised exanthematous pustulosis (37) Pruritus (33) Drug reaction with eosinophilia and systemic symptoms (24) Eosinophilia (24) Rash (22) Acute motor-sensory axonal neuropathy (19) Pyrexia (18) Condition aggravated (17)

What Other Drugs Cause Product use in unapproved indication?

DUPILUMAB (33,452) DICLOFENAC (12,197) METHOTREXATE (8,930) PREDNISONE (7,625) RITUXIMAB (7,519) MYCOPHENOLATE MOFETIL (5,910) ACETAMINOPHEN (5,819) CYCLOPHOSPHAMIDE (5,750) RISPERIDONE (5,551) TACROLIMUS (5,057)

Which ECONAZOLE Alternatives Have Lower Product use in unapproved indication Risk?

ECONAZOLE vs ECULIZUMAB ECONAZOLE vs EDARAVONE ECONAZOLE vs EDETATE ECONAZOLE vs EDOXABAN ECONAZOLE vs EDOXABAN TOSILATE

Related Pages

ECONAZOLE Full Profile All Product use in unapproved indication Reports All Drugs Causing Product use in unapproved indication ECONAZOLE Demographics